[go: up one dir, main page]

DK3421042T3 - Indånding af nitrogenoxid til behandling af luftvejssygdomme - Google Patents

Indånding af nitrogenoxid til behandling af luftvejssygdomme Download PDF

Info

Publication number
DK3421042T3
DK3421042T3 DK18187122.9T DK18187122T DK3421042T3 DK 3421042 T3 DK3421042 T3 DK 3421042T3 DK 18187122 T DK18187122 T DK 18187122T DK 3421042 T3 DK3421042 T3 DK 3421042T3
Authority
DK
Denmark
Prior art keywords
inhalation
treatment
nitrogen oxide
respiratory diseases
respiratory
Prior art date
Application number
DK18187122.9T
Other languages
English (en)
Inventor
Yossef Av-Gay
Christopher C Miller
David Greenberg
Original Assignee
Beyond Air Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beyond Air Ltd filed Critical Beyond Air Ltd
Application granted granted Critical
Publication of DK3421042T3 publication Critical patent/DK3421042T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • A61B5/0833—Measuring rate of oxygen consumption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • A61B5/0836—Measuring rate of CO2 production
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • A61B5/4222—Evaluating particular parts, e.g. particular organs
    • A61B5/4244—Evaluating particular parts, e.g. particular organs liver
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A61M16/122—Preparation of respiratory gases or vapours by mixing different gases with dilution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3303—Using a biosensor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/202—Blood composition characteristics partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/207—Blood composition characteristics hematocrit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK18187122.9T 2012-03-07 2013-03-07 Indånding af nitrogenoxid til behandling af luftvejssygdomme DK3421042T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261607686P 2012-03-07 2012-03-07
EP13757959.5A EP2822564B1 (en) 2012-03-07 2013-03-07 Inhalation of nitric oxide for treating respiratory diseases

Publications (1)

Publication Number Publication Date
DK3421042T3 true DK3421042T3 (da) 2024-07-22

Family

ID=49116038

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18187122.9T DK3421042T3 (da) 2012-03-07 2013-03-07 Indånding af nitrogenoxid til behandling af luftvejssygdomme
DK13757959.5T DK2822564T3 (da) 2012-03-07 2013-03-07 Inhalering af nitrogenoxid til behandling af luftvejssygdomme

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13757959.5T DK2822564T3 (da) 2012-03-07 2013-03-07 Inhalering af nitrogenoxid til behandling af luftvejssygdomme

Country Status (7)

Country Link
US (10) US20150034084A1 (da)
EP (5) EP2822566A4 (da)
CA (1) CA2865876A1 (da)
DK (2) DK3421042T3 (da)
ES (2) ES2988619T3 (da)
IL (1) IL234508B (da)
WO (5) WO2013132498A2 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3421042T3 (da) * 2012-03-07 2024-07-22 Beyond Air Ltd Indånding af nitrogenoxid til behandling af luftvejssygdomme
CN105283213B (zh) 2013-03-15 2018-10-16 通用医疗公司 一氧化氮的吸气合成
EP3431129B1 (en) 2013-03-15 2025-08-06 The General Hospital Corporation Synthesis of nitric oxide gas for inhalation
WO2015058127A1 (en) * 2013-10-18 2015-04-23 Bovicor Pharmatech Inc. Preparation and delivery of sustained nitric oxide releasing solutions
US20160271056A1 (en) * 2013-12-23 2016-09-22 Nitric Solutions Inc. Cystic fibrosis treatment comprising nitric oxide
WO2015157524A1 (en) * 2014-04-09 2015-10-15 12th Man Technologies, Inc. Systems and methods for high concentration nitric oxide delivery
EP3197464A4 (en) * 2014-08-25 2018-01-17 Advanced Inhalation Therapies (AIT) Ltd. Treatment of inflammation, respiratory tract infections and cystic fibrosis
CN107073239A (zh) 2014-10-20 2017-08-18 通用医疗公司 用于合成一氧化氮的系统和方法
GB2533125A (en) * 2014-12-10 2016-06-15 Cambridge Respiratory Innovations Ltd Capnometer
WO2016191506A1 (en) * 2015-05-25 2016-12-01 Geno Llc Nitric oxide treatment system and method
KR102363923B1 (ko) * 2015-09-09 2022-02-21 어드밴스드 인헐레이션 테라피즈 (에이아이티) 리미티드 세기관지염이 있는 유아를 위한 산화질소 흡입 치료
WO2017130066A1 (en) * 2016-01-27 2017-08-03 Advanced Inhalation Therapies (Ait) Ltd. Methods of treatment of respiratory tract infections and cystic fibrosis
JP6936804B2 (ja) * 2016-01-27 2021-09-22 アドバンスド インハレイション セラピーズ （エイアイティー） リミテッド 治療ガスおよび診断ガスの吸入システムおよびその使用方法
WO2017147295A1 (en) * 2016-02-25 2017-08-31 The Regents Of The University Of Michigan Nitric oxide generating formulations and kits
US11617850B2 (en) 2016-03-25 2023-04-04 The General Hospital Corporation Delivery systems and methods for electric plasma synthesis of nitric oxide
CN110573454B (zh) 2017-02-27 2021-08-20 第三极股份有限公司 生成一氧化氮的系统和方法
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
CA3151184A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
BR112019020317A2 (pt) 2017-03-31 2020-04-28 Massachusetts Gen Hospital sistemas e métodos para um gerador de óxido nítrico resfriado
WO2019090075A1 (en) * 2017-11-02 2019-05-09 Ait Therapeutics, Inc. Inhalation of nitric oxide
WO2019090080A1 (en) * 2017-11-02 2019-05-09 Ait Therapeutics, Inc. Inhalation of nitric oxide
WO2020232419A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Systems and methods for generating nitric oxide
CN114269685A (zh) 2019-05-15 2022-04-01 第三极股份有限公司 用于一氧化氮生成的电极
EP3969016A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ARCHITECTURES FOR THE PRODUCTION OF NITROUS OXIDE
BR112022010072A2 (pt) 2019-11-25 2022-08-30 Beyond Air Inc Métodos que empregam óxido nítrico gasoso para inibir crescimento de tumor
WO2021142472A1 (en) 2020-01-11 2021-07-15 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
WO2021178574A1 (en) * 2020-03-05 2021-09-10 Know Bio, Llc Methods and systems for nitric oxide therapy for the treatment or prevention of respiratory infections
WO2021207184A1 (en) * 2020-04-07 2021-10-14 Bellerophon Therapeutics USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
GB202007928D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New uses and methods
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
BR112023003663A2 (pt) * 2020-08-28 2023-04-04 Beyond Air Inc Tratamento de tumores pulmonares primários e/ou secundários utilizando inalação de óxido nítrico gasoso
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
US20230062537A1 (en) * 2021-08-31 2023-03-02 Jose Hernandez Therapy of oxygen pulses for treating neurodegenerative disorders such as Parkinson Disease (PD), Alzheimer’s Disease (AD), Amiotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND) and other dementias, and Lymphedema, Arthritis and Depression
JP2024534608A (ja) 2021-09-23 2024-09-20 サード ポール，インコーポレイテッド 一酸化窒素を送達するシステム及び方法
TW202345876A (zh) * 2022-01-04 2023-12-01 美商貝勒羅豐治療公司 吸入式一氧化氮（ｉＮＯ）用於治療患有與類肉瘤病相關之肺高血壓（ＰＨ－ＳＡＲＣ）的患者之用途
CN114588467B (zh) * 2022-04-01 2022-11-29 广州蓝仕威克医疗科技有限公司 一种基于气体混合比例供气解决酒精中毒的方法及呼吸机

Family Cites Families (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
SE8603252L (sv) 1985-07-30 1987-01-31 Glaxo Group Ltd Anordning for att tillfora lekemedel till patienter
US4889116A (en) 1987-11-17 1989-12-26 Phospho Energetics, Inc. Adaptive control of neonatal fractional inspired oxygen
US5356890A (en) 1988-06-15 1994-10-18 Brigham And Women's Hospital S-nitroso derivatives of ace inhibitors and the use thereof
DE3823382C1 (da) 1988-07-09 1990-01-11 Draegerwerk Ag, 2400 Luebeck, De
US4954526A (en) 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5208233A (en) 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5039705A (en) 1989-09-15 1991-08-13 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
IT1240750B (it) 1990-04-12 1993-12-17 Chiesi Farma Spa Dispositivo per la somministrazione di sostanze medicamentose in polvere
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5155137A (en) 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines
GB9026191D0 (en) 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
DK0560928T3 (da) 1990-12-05 1997-12-01 Gen Hospital Corp Anordninger til behandling af pulmonal vasokonstriktion og astma
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
US5394866A (en) 1991-03-05 1995-03-07 Aradigm Corporation Automatic aerosol medication delivery system and methods
US5380758A (en) 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
ES2141108T3 (es) 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
US5352461A (en) 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE69333443T2 (de) 1992-04-09 2005-03-24 Omron Healthcare Co., Ltd. Ultraschallzerstäuber
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5525357A (en) 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5632981A (en) 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5285794A (en) 1992-12-14 1994-02-15 Temple University Of The Commonwealth System Of Higher Education Respiratory gas monitor
WO1994014492A2 (en) 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
US5694919A (en) 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US5507277A (en) 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US5888477A (en) 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
GB9303335D0 (en) 1993-02-19 1993-04-07 Bespak Plc Inhalation apparatus
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
SE9302550D0 (sv) 1993-07-30 1993-07-30 Ernst Hoerlin Powder inhaler
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
PT101450B (pt) 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
FI95441C (fi) 1994-05-31 1996-02-12 Leiras Oy Inhalointilaitteen lääkeainekammio
US5509404A (en) 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
JP3706136B2 (ja) 1994-09-21 2005-10-12 ネクター セラピューティクス 乾燥粉末薬剤の分散装置及び方法
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
FR2725626A1 (fr) 1994-10-18 1996-04-19 Sofab Dispositif pour l'inhalation de produits en poudre
SE9404439D0 (sv) 1994-12-21 1994-12-21 Astra Ab Inhalation device
CA2187288A1 (en) 1995-02-08 1996-08-15 Edwin B. Merrick Gas mixing apparatus for a ventilator
US5823180A (en) * 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US5780014A (en) 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US6428771B1 (en) 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
ATE209518T1 (de) 1995-06-21 2001-12-15 Asta Medica Ag Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator
DE19523516C1 (de) 1995-06-30 1996-10-31 Asta Medica Ag Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
US6209538B1 (en) 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
FR2738153B1 (fr) 1995-09-04 1998-01-02 Valois Appareil d'inhalation destine a distribuer des doses precises et reproductibles de produit pulverulent
RU2072241C1 (ru) 1995-09-20 1997-01-27 Панина Елена Владимировна Способ формирования дыхательной газовой смеси и аппарат для его осуществления
US5724986A (en) 1995-11-06 1998-03-10 Jones Medical Instrument Co. Casing and spirometer for metered dose inhaler
US6182655B1 (en) 1995-12-07 2001-02-06 Jago Research Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US5797392C1 (en) 1996-01-22 2001-01-09 Direct Haler As Inhaler
US6026809A (en) 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
AP897A (en) 1996-04-05 2000-11-17 Massachusetts Gen Hospital Use of gaseous nitric oxide for the manufacturing of a therapeutic gas for the treatment of hemoglobinopathy.
GB2316323B (en) 1996-06-20 1999-09-22 Aid Medic Ltd Dispensing system
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
AU5863898A (en) 1997-01-17 1998-08-07 Messer Griesheim Austria Ges.M.B.H Controlled gas-supply system
PT101988B (pt) 1997-04-04 2004-02-27 Hovione Farmaciencia Sa Sistema de orientacao e posicionamento de um objecto
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
EP0984805B1 (en) 1997-05-23 2004-11-10 PA Knowledge Limited Inhaler mechanism
US6232336B1 (en) 1997-07-03 2001-05-15 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
NZ504021A (en) 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
WO1999027920A2 (en) 1997-12-03 1999-06-10 Britannia Pharmaceuticals Limited Use of phospholipids for the manufacture of a medicament for the treatment of asthma
EP1060174B1 (en) 1997-12-23 2004-09-22 Amersham Health AS Nitric oxide releasing chelating agents and their therapeutic use
GB9805102D0 (en) 1998-03-10 1998-05-06 Ciba Geigy Ag Device
AP1342A (en) 1998-03-16 2004-12-15 Nektar Therapeutics Aerosolized active agent delivery.
DE69820455D1 (de) 1998-04-03 2004-01-22 Kos Pharma Inc Inhalator
US6089229A (en) 1998-05-26 2000-07-18 Datex-Ohmeda, Inc. High concentration no pulse delivery device
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
JP2002518432A (ja) 1998-06-24 2002-06-25 アドバンスト インハレーション リサーチ，インコーポレイテッド 吸入器から放出される大多孔性粒子
JP4416325B2 (ja) 1998-08-25 2010-02-17 アルカーメス，インコーポレイテッド 安定な噴霧乾燥タンパク質製剤
US20070086954A1 (en) 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
CA2254645A1 (en) 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US20070275100A1 (en) * 1998-11-23 2007-11-29 Miller Christopher C Use of gaseous nitric oxide as an anti-cancer agent
FR2787031B1 (fr) 1998-12-11 2001-03-30 Valois Sa Dispositif d'inhalation ameliore
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
GB9903433D0 (en) 1999-02-15 1999-04-07 The Technology Partnership Plc Droplet generation method and device
IT1309592B1 (it) 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
AU3409399A (en) 1999-03-05 2000-09-28 Chiesi Farmaceutici S.P.A. Improved powdery pharmaceutical compositions for inhalation
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
ATE390944T1 (de) 1999-07-23 2008-04-15 Mannkind Corp Einzelportionskapseln für einen trockenpulverinhalator
US6612306B1 (en) 1999-10-13 2003-09-02 Healthetech, Inc. Respiratory nitric oxide meter
US6367471B1 (en) 1999-11-01 2002-04-09 Sheffield Pharmaceuticals, Inc. Internal vortex mechanism for inhaler device
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
US6581599B1 (en) 1999-11-24 2003-06-24 Sensormedics Corporation Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US6758214B2 (en) 2000-01-28 2004-07-06 Cyterra Corporation Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
US6427688B1 (en) 2000-02-01 2002-08-06 Dura Pharmaceuticals, Icn. Dry powder inhaler
JP4934798B2 (ja) 2000-03-10 2012-05-16 オーリエル・セラピューティクス・インコーポレイテッド 乾燥粉末吸入装置、複数投与分乾燥粉末薬剤パッケージ、制御システム、及び関連方法
DE10013093B4 (de) 2000-03-17 2005-12-22 Inamed Gmbh Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
US7255105B2 (en) 2000-10-16 2007-08-14 Pulmonox Technologies Corporation System for use in administrating therapeutic gas to a patient
US6359182B1 (en) 2000-10-26 2002-03-19 Duke University C-nitroso compounds and use thereof
SE0004229D0 (sv) * 2000-11-17 2000-11-17 Aga Ab Inhalation of nitric oxide
AUPR164400A0 (en) * 2000-11-23 2000-12-14 Emphatec Pty Ltd Nitric oxide donor compounds and methods of treatment using same
JP4590091B2 (ja) 2000-11-24 2010-12-01 大陽日酸株式会社 ガス分析装置
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7335181B2 (en) 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
KR20040023597A (ko) 2001-05-10 2004-03-18 벡투라 딜리버리 디바이시스 리미티드 흡입기들
DE10123749A1 (de) 2001-05-16 2002-12-12 Inamed Gmbh Vorrichtung zum Verabreichen von Aerosolen
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
FI20011317A0 (fi) 2001-06-20 2001-06-20 Orion Corp Jauheinhalaattori
US8221329B2 (en) 2001-07-31 2012-07-17 The United State Of America As Represented By The Secretary Of The Army Inhalation system and method
EP1429829B1 (en) 2001-09-05 2013-11-27 Geno LLC Nitric oxide generation
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
AU2002350622B2 (en) 2001-10-24 2006-09-14 Pari Pharma Gmbh Kit for the preparation of a pharmaceutical composition
WO2003041777A1 (en) 2001-11-14 2003-05-22 Nektar Therapeutics Aerosolization device with improved endpiece connection
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
GB2384190A (en) 2002-01-22 2003-07-23 Bespak Plc Dispensing device for a powdered product
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
CN1674942A (zh) 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
US20070065473A1 (en) 2002-07-09 2007-03-22 Miller Christopher C Nitric oxide gas (gO) as a cosmetic and wound healing agent
DE10239321B3 (de) 2002-08-27 2004-04-08 Pari GmbH Spezialisten für effektive Inhalation Aerosoltherapievorrichtung
US7056494B2 (en) 2002-09-03 2006-06-06 Kos Pharmaceuticals, Inc. Method of treating a systemic disease
US7531133B2 (en) 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US20040102469A1 (en) 2002-09-13 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for reducing the mortality rate
GB0222023D0 (en) 2002-09-21 2002-10-30 Aventis Pharma Ltd Inhaler
AU2003286786A1 (en) 2002-10-30 2004-06-07 Nektar Therapeutics Increased dosage metered dose inhaler
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
US8251057B2 (en) 2003-06-30 2012-08-28 Life Support Technologies, Inc. Hyperbaric chamber control and/or monitoring system and methods for using the same
EP1522325B1 (en) 2003-10-06 2007-06-13 Bang & Olufsen Medicom A/S Inhaler
GB2407042B (en) 2003-10-17 2007-10-24 Vectura Ltd Inhaler
EP1691685A4 (en) 2003-11-17 2008-09-03 Spirojet Medical Ltd SPIROMETER
US20050255178A1 (en) * 2004-02-04 2005-11-17 Bloch Kenneth D Enhancing the effectiveness of an inhaled therapeutic gas
US7569559B2 (en) 2004-02-09 2009-08-04 Noxilizer, Inc. Nitric oxide-releasing molecules
WO2005081752A2 (en) 2004-02-09 2005-09-09 Amulet Pharmaceuticals, Inc. Nitric oxide-releasing polymers
CA2561845C (en) 2004-04-02 2014-03-25 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Aerosol delivery systems and methods
AU2005244079A1 (en) 2004-05-11 2005-11-24 Pulmonox Technologies Corporation The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
CA2563493A1 (en) 2004-05-11 2005-11-24 Sensormedics Corporation Intermittent dosing of nitric oxide gas
US8518457B2 (en) 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2006023616A2 (en) 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US7968664B2 (en) 2004-09-27 2011-06-28 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
WO2007057763A2 (en) 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
PT1981572E (pt) 2006-02-09 2013-02-26 Pari Pharma Gmbh Distribuição pulmonar de inibidor de alfa-i proteinase
US8079998B2 (en) 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
EP1927373B1 (en) 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
US20080193566A1 (en) 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
US7941441B2 (en) 2007-02-12 2011-05-10 Ocean Observations Ab Media data access system and method
US8273828B2 (en) 2007-07-24 2012-09-25 Medtronic Vascular, Inc. Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation
AR076731A1 (es) 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
US20100040701A1 (en) * 2008-08-12 2010-02-18 Neal Schwartz Compound for exfoliating skin
WO2010017633A1 (en) 2008-08-13 2010-02-18 Chris Miller Use of nitric oxide
US8158187B2 (en) 2008-12-19 2012-04-17 Medtronic Vascular, Inc. Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices
EP2401013B1 (en) 2009-02-27 2017-04-12 PARI GmbH Spezialisten für effektive Inhalation An aerosol inhalation device
WO2010151505A1 (en) 2009-06-22 2010-12-29 Geno Llc Nitric oxide therapies
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
WO2011004476A1 (ja) 2009-07-09 2011-01-13 パイオニア株式会社 スピーカ装置
CA2781295C (en) 2009-11-20 2018-02-13 Geno Llc Nitric oxide delivery system
US8499252B2 (en) 2009-12-18 2013-07-30 Covidien Lp Display of respiratory data graphs on a ventilator graphical user interface
EP2531249B1 (en) 2010-02-01 2021-03-24 VERO Biotech LLC Nitric oxide delivery system
WO2011116336A1 (en) 2010-03-19 2011-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
AU2011245476B2 (en) 2010-04-26 2016-05-12 VERO Biotech LLC. Delivery of ultra pure nitric oxide (NO)
EP2563440A4 (en) 2010-04-26 2017-06-21 Geno LLC Nitrosyl special connector
DK3421042T3 (da) 2012-03-07 2024-07-22 Beyond Air Ltd Indånding af nitrogenoxid til behandling af luftvejssygdomme
US20160022731A1 (en) 2013-03-07 2016-01-28 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
US20150072023A1 (en) 2013-09-11 2015-03-12 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
CA2926046A1 (en) 2013-09-11 2015-03-19 Advanced Inhalation Therapies (Ait) Ltd. System for nitric oxide inhalation
EP2937089A1 (en) 2014-04-23 2015-10-28 Linde AG Device for the treatment of, treatment of complications arising from, and/or prevention of respiratory disorders
EP3197464A4 (en) 2014-08-25 2018-01-17 Advanced Inhalation Therapies (AIT) Ltd. Treatment of inflammation, respiratory tract infections and cystic fibrosis
US10039781B2 (en) 2015-03-24 2018-08-07 Ait Therapeutics, Inc. Pulse inhalation of nitric oxide for treating respiratory diseases
KR102363923B1 (ko) 2015-09-09 2022-02-21 어드밴스드 인헐레이션 테라피즈 (에이아이티) 리미티드 세기관지염이 있는 유아를 위한 산화질소 흡입 치료
WO2017130066A1 (en) 2016-01-27 2017-08-03 Advanced Inhalation Therapies (Ait) Ltd. Methods of treatment of respiratory tract infections and cystic fibrosis

Also Published As

Publication number Publication date
ES2988619T3 (es) 2024-11-21
US20180125883A1 (en) 2018-05-10
EP2822564B1 (en) 2018-09-12
CA2865876A1 (en) 2013-09-12
WO2013132497A1 (en) 2013-09-12
WO2013132503A1 (en) 2013-09-12
EP2822563A1 (en) 2015-01-14
US12478640B2 (en) 2025-11-25
WO2013132498A3 (en) 2015-06-18
WO2013132498A2 (en) 2013-09-12
EP2822566A4 (en) 2015-08-05
US20240238332A1 (en) 2024-07-18
US20150272988A1 (en) 2015-10-01
US20150044305A1 (en) 2015-02-12
EP3421042B1 (en) 2024-04-17
ES2690398T3 (es) 2018-11-20
US20220047623A1 (en) 2022-02-17
EP2822565A4 (en) 2016-05-04
US20180133246A1 (en) 2018-05-17
EP2822564A4 (en) 2015-08-05
DK2822564T3 (da) 2018-11-19
EP2822563A4 (en) 2015-08-05
US20200276229A1 (en) 2020-09-03
US20150174158A1 (en) 2015-06-25
WO2013132499A1 (en) 2013-09-12
EP2822564A1 (en) 2015-01-14
IL234508B (en) 2020-09-30
WO2013132500A1 (en) 2013-09-12
EP3421042A1 (en) 2019-01-02
EP2822565A2 (en) 2015-01-14
EP2822566A1 (en) 2015-01-14
US20150034084A1 (en) 2015-02-05
US20200215102A1 (en) 2020-07-09

Similar Documents

Publication Publication Date Title
DK3421042T3 (da) Indånding af nitrogenoxid til behandling af luftvejssygdomme
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
IL253225B (en) Sulfamoyl-arylamides and their use as drugs to treat jaundice b
LT3470063T (lt) Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
PL2852391T3 (pl) Układy do leczenia infekcji płuc
DK2895156T3 (da) Fremgangsmåde til fremstilling af terapeutiske nanopartikler
DK3108966T3 (da) Inhalator
DK3117862T3 (da) Åndedrætsmaske
DK2708255T3 (da) Inhalator
GB2506621B (en) Respiratory mask
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
DK2806934T3 (da) Luftvejsanordning
EP2542285C0 (en) INHALER
DK2818241T3 (da) Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur
PL2627345T3 (pl) Preparaty do leczenia chorób górnych dróg oddechowych
AU339359S (en) Respiratory mask and/or components thereof
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
IL234606B (en) Novel methods and composition for treatment of disease
DK3035885T3 (da) Inhalator
IL245412A0 (en) Polylinosinic-polycytidylic acid formulations for the treatment of upper respiratory tract infections
PL2934134T3 (pl) Zastosowania inhalacji kwasem acetylosalicylowym
DK2900259T3 (da) Glycosidase-regime til behandling af infektionssygdomme
DK3035887T3 (da) Inhalator
DK2892556T3 (da) Sammensætninger og fremgangsmåder til behandling af sygdomme